Study guide

Platelet And Coagulation Physiology

ASCP MLS Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Orientation To ASCP MLS Certification

Credential Purpose And Role ASCP BOC And Eligibility At A High Level MLS Versus MLS(ASCPi) Wording Application Fee And Transcript Result Basics CAT Exam Model Overview Study Plan From Content Guideline

2 Exam Format, CAT Scoring, And Score details

100 Questions And 2h30m Computer Adaptive Testing One-Best-Answer Multiple Choice Theoretical Versus Procedural Questions Scaled Score 100-999, Minimum 400 Score Notification Timing And Transcript Dependency

3 Blood Banking

Products And Components Blood Group Systems And Immunology Serologic And Molecular Testing Compatibility Testing And Transfusion Practice Physiology And Pathophysiology High-Yield Study Strategy

4 Chemistry

Carbohydrates, Lipids, Proteins, And Nitrogen Compounds Enzymes And Heme Derivatives Acid-Base, Blood Gases, And Electrolytes Endocrinology, Vitamins, And Nutrition Therapeutic Drug Monitoring And Toxicology Calculations And Correlation

5 Hematology And Hemostasis

Normal Hematopoiesis And Cell Morphology Anemia And RBC Disorders Leukocyte Disorders And Disease States Platelet And Coagulation Physiology Hemostasis Testing Smear, Analyzer, And Result Correlation

6 Microbiology

Preanalytic Specimen Handling Bacteriology Analytic Procedures Susceptibility And Organism Identification Logic Mycobacteriology, Virology, Parasitology, And Mycology Postanalytic Reporting Safety And Contamination Awareness

7 Urinalysis And Other Body Fluids

Physical And Chemical Urinalysis Microscopic Sediment Renal Physiology And Disease States CSF And Serous Fluids Body Fluid Cell Counts And Crystals Correlation And Preanalytic Issues

8 Immunology

Principles Of Immune Response Immune-System Diseases Infectious Disease Serology Transplantation And Compatibility Concepts Serologic Procedures And Test Methodology Interpretation Pitfalls

9 Laboratory Operations

Quality Assessment And Troubleshooting Safety Laboratory Mathematics Manual And Automated Methodology Instrumentation And Validation Management And Education Principles

10 Integrated Case Reasoning And Calculations

Correlating Patient Results To Disease States Applying Knowledge To New Facts Calculations And Units Procedural Decision-Making QA/QC In Case Questions Avoiding Memorization-Only Study

11 Practice Strategy And Remediation

Content Percentage Allocation CAT-Aware Practice Mindset Reviewing Misses By Domain Using The Official Guideline Before Third-Party Materials Transcript And Result Timing In Planning Final Remediation Cycles

12 Final Review And Exam-Day Readiness

Final-Week Schedule Timing And Pacing Score Expectations Result And Credential Next Steps Digital Badge And Documentation Post-Exam Actions Without Promises

Platelet And Coagulation Physiology

Key Takeaways Explain This Topic AI

Primary hemostasis = platelet plug (vWF-mediated adhesion); secondary hemostasis = fibrin clot via the coagulation cascade.

The intrinsic pathway (factors XII, XI, IX, VIII) is monitored by aPTT; the extrinsic pathway (factor VII + tissue factor) is monitored by PT.

The common pathway is factors X, V, II (prothrombin), and I (fibrinogen).

Vitamin K is required for factors II, VII, IX, X and proteins C and S; warfarin blocks this and prolongs PT first.

Last updated: June 2026

Primary Hemostasis: The Platelet Plug

Primary hemostasis is the rapid formation of a platelet plug at a site of vascular injury. Platelets adhere to exposed subendothelial collagen via von Willebrand factor (vWF) binding the platelet GPIb receptor. They then activate , release granule contents (ADP, thromboxane A2), and aggregate to one another through GPIIb/IIIa receptors bridged by fibrinogen.

Know the receptor-defect diseases:

Disorder Defect Key lab clue

von Willebrand disease Deficient/defective vWF Long bleeding time, abnormal ristocetin aggregation, may prolong aPTT (low factor VIII)

  • Bernard-Soulier GPIb defect Giant platelets, abnormal ristocetin
  • Glanzmann thrombasthenia GPIIb/IIIa defect Normal ristocetin, abnormal ADP/collagen/epinephrine aggregation

A tested discriminator: ristocetin aggregation is abnormal in vWD and Bernard-Soulier but normal in Glanzmann (because Glanzmann is an aggregation, not adhesion, defect).

Platelets are not just structural - they contribute biochemically. Activated platelets release dense granules (ADP, serotonin, calcium) and alpha granules (fibrinogen, vWF, platelet-derived growth factor) and synthesize thromboxane A2 from arachidonic acid via cyclooxygenase. Aspirin irreversibly acetylates cyclooxygenase , abolishing thromboxane A2 for the platelet's lifespan (about 7-10 days), which is why aspirin's antiplatelet effect outlasts the drug in the blood.

The pattern of bleeding helps localize the defect on the exam: platelet/vascular (primary hemostasis) defects cause mucocutaneous bleeding - petechiae, epistaxis, gum bleeding, menorrhagia - whereas coagulation factor (secondary hemostasis) defects cause deep bleeding - hemarthroses, muscle hematomas, delayed bleeding after trauma.

Secondary Hemostasis: The Coagulation Cascade

Secondary hemostasis converts the platelet plug into a stable fibrin clot. The cascade has three arms:

Intrinsic pathway: factors XII, XI, IX, VIII - monitored by the activated partial thromboplastin time (aPTT) .

Extrinsic pathway: factor VII + tissue factor - monitored by the prothrombin time (PT) .

Common pathway: factors X, V, II (prothrombin), I (fibrinogen) - prolongs both PT and aPTT.

Thrombin (factor IIa) converts fibrinogen to fibrin; factor XIII cross-links fibrin into a stable clot. A mnemonic for which test catches which factor: "PeT the extrinsic dog (VII = PT); the intrinsic table (aPTT) has 8, 9, 11, 12."

A powerful exam shortcut is to reason backward from PT/aPTT patterns to the deficient factor: prolonged PT only isolates factor VII (extrinsic); prolonged aPTT only isolates an intrinsic factor (VIII, IX, XI, or XII); both prolonged points to a common-pathway factor (X, V, II, or fibrinogen) or a global problem such as liver disease, DIC, or vitamin K deficiency. Note that factor XII deficiency prolongs the aPTT but does not cause bleeding - it is a classic distractor because the long aPTT looks alarming yet is clinically silent.

Hemophilia A (factor VIII) and hemophilia B (factor IX, "Christmas disease") both prolong only the aPTT and are X-linked recessive, so they predominantly affect males. Factor XIII deficiency is unique: PT and aPTT are normal because the clot forms, but it is unstable and dissolves, so the screening test is clot solubility in 5M urea .

Vitamin K-Dependent Factors

Factors II, VII, IX, X and the natural anticoagulants protein C and protein S require vitamin K for gamma-carboxylation. Warfarin inhibits vitamin K epoxide reductase, so these factors fall. Because factor VII has the shortest half-life (~6 hours) , the PT prolongs first on warfarin, which is why PT/INR monitors warfarin therapy.

Natural Anticoagulants

Clotting is restrained by:

Antithrombin (III): inhibits thrombin and factor Xa; potentiated by heparin.

Protein C / Protein S: inactivate factors Va and VIIIa.

Tissue factor pathway inhibitor (TFPI): blocks the VIIa-tissue factor complex.

Factor V Leiden is a mutation making factor Va resistant to protein C cleavage - the most common inherited thrombophilia. Other inherited thrombophilias the exam may list include the prothrombin G20210A mutation, and deficiencies of antithrombin, protein C, or protein S. The balance between procoagulant and anticoagulant forces is dynamic: a deficiency on the anticoagulant side (for example protein C deficiency) tips toward thrombosis, while a deficiency on the procoagulant side (for example factor VIII) tips toward bleeding. This is why the same cascade diagram explains both hemophilia and hypercoagulable states.

The fibrinolytic system completes the loop: plasminogen is converted to plasmin by tissue plasminogen activator (tPA), and plasmin digests fibrin into fibrin degradation products and D-dimer , the marker of clot breakdown used clinically and tested in the next section.

Worked Example

A child has easy bruising, a prolonged aPTT, a normal PT, and a markedly low factor VIII. Because the intrinsic pathway (aPTT) is affected while the extrinsic (PT) is normal, and factor VIII is the deficient factor, this is hemophilia A , an X-linked factor VIII deficiency.

Contrast this with von Willebrand disease , the most common inherited bleeding disorder, where low vWF impairs platelet adhesion and also lowers factor VIII (vWF is its carrier), giving mucocutaneous bleeding, a long bleeding time/PFA closure time, and sometimes a mildly prolonged aPTT - a useful overlap the exam exploits to test whether you understand that vWF and factor VIII travel together in plasma.

Common Traps

Mixing up which test monitors which drug: PT/INR for warfarin, aPTT for unfractionated heparin .

Forgetting that factor VII (extrinsic) is not in the intrinsic pathway, so its deficiency prolongs only the PT.

Assuming vWD is a platelet-count problem - the platelet count is usually normal; the defect is adhesion.